Benitec Biopharma appoints Ernst & Young as independent auditor for FY2027

Bitget2026/09/30 20:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Benitec Biopharma engaged Ernst & Young as its independent registered public accounting firm for the fiscal year ending June 30, 2027.
EY completed its client acceptance procedures on Sept. 28, 2026.
An engagement letter with EY was executed on Sept. 29, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Benitec Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-409052), on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Benitec Biopharma appoints Ernst & Young as independent auditor for FY2027

You may also like

Crypto prices